In ovarian cancer (OC), zinc transporters ZIP4/ZIP13 promote aggressiveness via independent pathways; overexpressed ZIP4 drives drug resistance and tumorigenesis via increased expression of the stem cell marker NOTCH3 (215). Here, SLC39A13 is linked to ovarian carcinoma.